PharmaShots | Incisive News in 3 Shots

Subscribe Now

US WorlMeds

US WorlMeds' Iwilfin Receives the US FDA's Approval for the Treatment of Children with Neuroblastoma

US WorlMeds' Iwilfin Receives the US FDA's Approval for the Treatment of Children with Neuroblastoma

December 14, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us